Merrimack Pharmaceuticals, Inc. (MACK)

4.13
NASDAQ
Prev Close 4.04
Day Low/High 3.99 / 4.16
52 Wk Low/High 3.83 / 9.45
Exchange NASDAQ
Shares Outstanding 13.41B
Market Cap 54.18M
P/E Ratio N/A
Div & Yield N.A. (N.A)
MACK: What's in the Pipeline

MACK: What's in the Pipeline

Bob Mulroy, CEO of Merrimack Pharmaceutical, reveals the innovation behind the company's quest to find treatments for cancer.